Antioxidants and Endothelial Function: Therapeutic Implications

  • B. A. Mullan
  • B. V. McCloskey


Endothelial function may be impaired in critically ill patients [1]. The endothelium actively regulates vascular tone, platelet aggregation, coagulation, fibrinolysis, and leukocyte activation [2]. Endothelial dysfunction may, therefore, be important in the pathophysiology of some of the conditions encountered in the intensive care unit (ICU).


Nitric Oxide Nitric Oxide Endothelial Dysfunction Endothelial Function Flavin Adenine Dinucleotide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cardigan R, McGloin H, Macki I, Machin S, Singer M (1998) Endothelial dysfunction in critically ill patients: the effect of haemofiltration. Intensive Care Med 24: 1264–1271PubMedCrossRefGoogle Scholar
  2. 2.
    De Caterina R (2000) Endothelial dysfunctions: common denominators in vascular disease. Curr Opin Clin Nutr Metab Care 3: 453–467PubMedCrossRefGoogle Scholar
  3. 3.
    Oldham KM, Bowen PE (1998) Oxidative stress in critical care: is antioxidant supplementation beneficial? J Am Diet Assoc 98: 1001–1008PubMedCrossRefGoogle Scholar
  4. 4.
    Goode HF, Webster NR (1993) Anti-oxidants in intensive care medicine. Clin Intensive Care 4: 265–270Google Scholar
  5. 5.
    Carr A, Frei B (2000) The role of natural antioxidants in preserving the biological activity of endothelium-derived nitric oxide. Free Radic Biol Med 28: 1806–1814PubMedCrossRefGoogle Scholar
  6. 6.
    Vallance P, Chan N (2001) Endothelial function and nitric oxide: clinical relevance. Heart 85: 342–350PubMedCrossRefGoogle Scholar
  7. 7.
    Haji-Michael PG (2000) Antioxidant therapy in the critically ill. Br J Intensive Care 10: 88–93Google Scholar
  8. 8.
    Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329: 20022012Google Scholar
  9. 9.
    Cockcroft JR, Wilkinson IB, Webb DJ (1997) Age, arterial stiffness and the endothelium. Age Ageing 26: 53–60PubMedCrossRefGoogle Scholar
  10. 10.
    Nichols WW, O’Rourke MF (1998) McDonald’s Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 4th edn. Arnold, LondonGoogle Scholar
  11. 11.
    Wilkinson IB, Cockcroft JR, Webb DJ (1998) Pulse wave analysis and arterial stiffness. J Cardiovasc Pharmacol 32 Suppl 3: S33 - S37Google Scholar
  12. 12.
    Cheeseman KH, Salter TF (1993) An introduction to free radical biochemistry. Br Med Bull 49: 481–493PubMedGoogle Scholar
  13. 13.
    Gryglewski RJ, Palmer RMJ, Moncada S (1986) Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320: 454–456PubMedCrossRefGoogle Scholar
  14. 14.
    Cosentino F, Luscher TF (1998) Tetrahydrobiopterin and endothelial function. Eur Heart J 19 (Suppl G): G3 - G8PubMedGoogle Scholar
  15. 15.
    Cosentino F, Katusic ZS (1995) Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation 91: 139–144PubMedCrossRefGoogle Scholar
  16. 16.
    Keaney JF, Guo Y, Cunningham D, Shwaery GT, Xu AM, Vita JA (1996) Vascular incorporation of a-tocopherol prevents endothelial dysfunction due to oxidised LDL by inhibiting protein kinase C stimulation. J Clin Invest 98: 386–394PubMedCrossRefGoogle Scholar
  17. 17.
    Weber C, Erl W (2000) Modulation of vascular cell activation, function, and apoptosis: role of antioxidants and nuclear factor-kappa B. Curr Topics Cell Regul 36: 217–235CrossRefGoogle Scholar
  18. 18.
    Altavilla D, Saitta A, Guarini S, et al (2001) Oxidative stress causes nuclear factor-kappa B activation in acute hypovolemic hemorrhagic shock. Free Radic Biol Med 30: 1055–1066PubMedCrossRefGoogle Scholar
  19. 19.
    Abello PA, Fidler SA, Buckley GB, Buchman TG (1994) Antioxidants modulate induction of programmed endothelial cell death (apoptosis) by endotoxin. Arch Surg 129: 134–140PubMedCrossRefGoogle Scholar
  20. 20.
    Browry VW, Mohr D, Clearly J, Stocker R (1995) Prevention of tocopherol-mediated peroxidation in ubiquinol-20-free human low density lipoprotein. J Biol Chem 270: 5756–5763CrossRefGoogle Scholar
  21. 21.
    Halliwell B (1996) Vitamin C: antioxidant or pro-oxidant in vivo. Free Radic Res 25: 439454Google Scholar
  22. 22.
    Maxwell SRJ (1995) Prospects for the use of antioxidant therapies. Drugs 49: 345–361PubMedCrossRefGoogle Scholar
  23. 23.
    Stehouwer CDA (1999) Is measurement of endothelial dysfunction clinically useful? Eur J Clin Invest 29: 459–461PubMedCrossRefGoogle Scholar
  24. 24.
    Smith FCT, Gosling P, Sanghera K, Green MA, Paterson IS, Shearman CP (1994) Microproteinuria predicts the severity of systemic effects of reperfusion injury following infrarenal aortic aneurysm surgery. Ann Vasc Surg 8: 1–5PubMedCrossRefGoogle Scholar
  25. 25.
    Shearman CY, Gosling P, Walker KJ (1989) Is low proteinuria an early predictor of severity of acute pancreatitis? J Clin Pathol 42: 1132–1135PubMedCrossRefGoogle Scholar
  26. 26.
    De Gaudio AR, Spina R, Di Filippo A, Feri M (1999) Glomerular permeability and trauma: a correlation between microalbuminuria and injury severity score. Crit Care Med 27: 21052108Google Scholar
  27. 27.
    Hack Ce, Zeerleder S (2001) The endothelium in sepsis: source of and target for inflammation. Crit Care Med 29 (Suppl): S21–527Google Scholar
  28. 28.
    Yamamoto K, Saito H (1998) A pathological role of increased expression of plasminogen activator inhibitor-1 in human or animal disorders. Int J Hematol 68: 371–385PubMedCrossRefGoogle Scholar
  29. 29.
    Hasdai D, Gibbons RJ, Holmes DR, Higano ST, Lerman A (1997) Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 96: 33903395Google Scholar
  30. 30.
    McAuliffe AV, Brooks BA, Fisher EJ, Molyneaux LM, Yue DK (1998) Administration of ascorbic acid and an aldose reductase inhibitor (tolrestat) in diabetes: effect on urinary albumin excretion. Nephron 80: 277–284PubMedCrossRefGoogle Scholar
  31. 31.
    Duffy SJ, Gokce N, Holbrook M, et al (1999) Treatment of hypertension with ascorbic acid. Lancet 354: 2048–2049PubMedCrossRefGoogle Scholar
  32. 32.
    Rossig L, Hoffmann J, Hugel B, et al (2001) Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation 104: 2182–2187PubMedCrossRefGoogle Scholar
  33. 33.
    Ceriello A (1997) Acute hyperglycaemia and oxidative stress generation. Diabetic Med 14: 545 - S49CrossRefGoogle Scholar
  34. 34.
    Beckman JA, Goldfine AB, Gordon MB, Creager MA (2001) Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 103: 1618–1623PubMedCrossRefGoogle Scholar
  35. 35.
    Marfella R, Verrazzo G, Acampora R, et al (1995) Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. Am J Physiol 268: E1167 - E1173PubMedGoogle Scholar
  36. 36.
    Ceriello A, Curcio F, dello Russo P, et al (1995) The defence against free radicals protects endothelial cells from hyperglycemia-induced plasminogen activator inhibitor-1 over-production. Blood Coagul Fibrinolysis 6: 133–137PubMedCrossRefGoogle Scholar
  37. 37.
    Ceriello A, Falleti E, Motz E, et al (1998) Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. Horm Metab Res 30: 146149Google Scholar
  38. 38.
    De Mattia G, Bravi MC, Laurenti O, et al (1998) Reduction of oxidative stress by oral Nacetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive patients with non-insulindependent diabetes. Diabetologia 41 (11): 1392–1396PubMedCrossRefGoogle Scholar
  39. 39.
    Goudev A, Kyurkchiev S, Gergova V, et al (2000) Reduced concentrations of soluble adhesion moleculs after antioxidant supplementation in postmenopausal women with high cardiovascular risk profiles–a randomised double-blind study. Cardiology 94: 227–232PubMedCrossRefGoogle Scholar
  40. 40.
    Schmidt H, Schmidt W, Muller T, Bohrer H, Gebhard MM, Martin E (1997) N-acetylcysteine attenuates endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo. Crit Care Med 25: 858–863PubMedCrossRefGoogle Scholar
  41. 41.
    Porter JM, Ivatury RR, Azimuddin K, Swami R (1999) Antioxidant therapy in the prevention of organ dysfunction syndrome and infections complications after trauma: early results of a prospective randomised study. Am Surg 65: 478–483PubMedGoogle Scholar
  42. 42.
    Tanaka H, Matsuda T, Miyagantani Y, Yukioka T, Matsuda H, Shimazaki S (2000) Reduction of resuscitation fluid volumes in severely burned patients using ascrobic acid administration. Arch Surg 135: 326–331PubMedCrossRefGoogle Scholar
  43. 43.
    Jackson TS, Xu A, Vita JA, Keaney JFJ (1998) Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 83: 916–922PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • B. A. Mullan
  • B. V. McCloskey

There are no affiliations available

Personalised recommendations